Skip to Content

APO PR .125 (Pramipexole Dihydrochloride 0.125 mg)

Pill with imprint APO PR .125 is White, Round and has been identified as Pramipexole dihydrochloride 0.125 mg. It is supplied by Apotex Corp..

Pramipexole is used in the treatment of restless legs syndrome; periodic limb movement disorder; parkinson's disease; tardive dyskinesia and belongs to the drug class dopaminergic antiparkinsonism agents. Risk cannot be ruled out during pregnancy. Pramipexole 0.125 mg is not a controlled substance under the Controlled Substance Act (CSA).

Images for APO PR .125

Pramipexole dihydrochloride

APO PR .125
0.125 mg
Prescription only
Drug Class:
Dopaminergic antiparkinsonism agents
Pregnancy Category:
C - Risk cannot be ruled out
CSA Schedule:
Not a controlled drug
Labeler / Supplier:
Apotex Corp.
National Drug Code (NDC):

Get help with Imprint Code FAQs.

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2018, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.